Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19
Our coalition of public health experts, doctors, and scientists worldwide want to draw attention to the need for high-quality evaluation protocols of the potential beneficial effect of hydroxychloroquine (HCQ) as a post-exposure drug for exposed people. In the absence of an approved, recognized effe...
Main Authors: | Stephane Picot, Aileen Marty, Anne-Lise Bienvenu, Lucille H. Blumberg, Jean Dupouy-Camet, Pierre Carnevale, Shigeyuki Kano, Malcolm K. Jones, Cláudio Tadeu Daniel-Ribeiro, Santiago Mas-Coma |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | One Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352771420300628 |
Similar Items
-
Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020
by: Anne-Lise Bienvenu, et al.
Published: (2020-12-01) -
Farmland Transitions in China: An Advocacy Coalition Approach
by: Xiaoping Zhou, et al.
Published: (2021-01-01) -
COVID-19 and globalization
by: Santiago Mas-Coma, et al.
Published: (2020-06-01) -
The advocacy coalition of sugar-sweetened beverage taxes in Indonesia
by: Yurdhina Meilissa, et al.
Published: (2023-11-01) -
Negotiating identity within the Sustainable Agriculture Advocacy Coalition
by: Merrigan, Kathleen Ann, 1959-
Published: (2005)